Literature DB >> 29019978

The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900.

Robert W Snow1,2, Benn Sartorius3, David Kyalo1, Joseph Maina1, Punam Amratia1, Clara W Mundia1, Philip Bejon1,2, Abdisalan M Noor1.   

Abstract

Malaria transmission is influenced by climate, land use and deliberate interventions. Recent declines have been observed in malaria transmission. Here we show that the African continent has witnessed a long-term decline in the prevalence of Plasmodium falciparum from 40% prevalence in the period 1900-1929 to 24% prevalence in the period 2010-2015, a trend that has been interrupted by periods of rapidly increasing or decreasing transmission. The cycles and trend over the past 115 years are inconsistent with explanations in terms of climate or deliberate intervention alone. Previous global initiatives have had minor impacts on malaria transmission, and a historically unprecedented decline has been observed since 2000. However, there has been little change in the high transmission belt that covers large parts of West and Central Africa. Previous efforts to model the changing patterns of P. falciparum transmission intensity in Africa have been limited to the past 15 years or have used maps drawn from historical expert opinions. We provide quantitative data, from 50,424 surveys at 36,966 geocoded locations, that covers 115 years of malaria history in sub-Saharan Africa; inferring from these data to future trends, we would expect continued reductions in malaria transmission, punctuated with resurgences.

Entities:  

Mesh:

Year:  2017        PMID: 29019978      PMCID: PMC5660624          DOI: 10.1038/nature24059

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


Short term seasonal cycles are a fundamental aspect of the epidemiology of malaria. Longer-term climate anomalies, changing environmental and intervention landscapes also alter the likelihoods of mosquito-human contact or the duration of host infection. The supra-seasonal, long-term cycles of transmission are poorly defined for P. falciparum malaria in Africa. To provide an empirical basis to define the long-term nature of malaria transmission cycles, we used data on the P. falciparum parasite rate, the proportion of persons positive for malaria infection among those examined. These data were assembled as part of an intensive search lasting 21 years (SI 1). The data represent the largest ever assembled repository of any parasitic disease in Africa and provide information on over 50,000 community-based surveys across SSA since 19004 (SI 1; Extended Data 1; Extended Data 2), the data are released with this publication. We have used the space-time cube of data to leverage power from neighbouring areas and preceding data points in time5, within a conditional autoregressive spatial and temporal model to compute a smoothed median estimate for approximately five-year intervals since 1900 across 520 sub-national administrative polygons (Extended Data 3) within the changing limits of P. falciparum transmission (Figure 1).
Extended Data 1

Survey data in time: The temporal distribution of survey data per intervals selected for analysis (number of surveys shown on top of bars)

Extended Data 2

Survey data in space: Location of 53,529 P. falciparum parasite surveys undertaken at 39,033 locations by time intervals from 1900-44 to 2010-15

Extended Data 3

The spatial range of P. falciparum Africa in between 1900-1950: light grey represents absence of natural P. falciparum transmission; pink is the natural extent of transmission; dark grey represents countries not included in the analysis

Figure 1

Changing spatial patterns of P. falciparum endemicity in sub-Saharan Africa since 1900.

Predicted posterior predictions of age standardised P. falciparum prevalence (PfPR2-10) per administrative unit on mainland SSA and Madagascar and masked (white) according to biological or control related absence of transmission (Methods and SI 2.2) and the reported changing spatial extents (Methods, SI 2.3, Source Data Figure 1).

The median posterior predictions of P. falciparum prevalence provide a summary of several important cycles in the history of malaria transmission across the continent (Figure 2). The impact of interventions and/or climate can only be assessed by temporal plausibility rather than quantitative analysis. Between 1900 and 1944, efforts to control malaria focused on areas of European economic influence, largely targeting vector larvae or mass quinine administration campaigns targeting the parasite6, and we did not observe declines in transmission.
Figure 2

Summary and plausibility framework of P. falciparum transmission cycles in sub-Saharan Africa since 1900

: The median, (central dark line) and 25-75% (medium green boundaries) and 2.5-97.5% (light green boundaries) interquartile credibility range of the posterior predictions of PfPR2-10 (Source Data Figure 2). : Six periods of major intervention: 1) 1900-1949: restricted efforts through larval control (LC), environmental management (EM) and mass drug administration (MDA) using Quinine (QN); 2) 1950-1969; launch of Global Malaria Eradication Programme (GMEP) in 1955, introduction of DDT and drugs (e.g. chloroquine (CQ) and pyrimethamine (PYR)) and pilot elimination projects involving indoor residual house-spraying (IRS) accompanied later by MDA using CQ and PYR; 3) 1970-1999: end of most vector control efforts, presumptive treatment of fevers with CQ, use of CQ as MDA for school children; 4) 2000-2004: the Roll Back Malaria (RBM) initiative with Insecticide Treated Nets (ITN) for vulnerable children and pregnant women, expansion of Intermittent Presumptive Treatment of malaria in pregnancy (IPTp) and failing first line treatment with Sulphadoxine-Pyrimethamine (SP) and/or CQ; 5) 2005-2010; large scale Long-Lasting Insecticide Treated Nets (LLIN) distributions, IRS expanded and switch from CQ or SP to Artemisinin-based Combination Therapy (ACT); 6) 2010-2015: increased IRS in many countries, scale-up of Rapid Diagnostic Tests (RDTs); the Global Technical Strategy (GTS) was launched in 2012, re-invigorating a global ambition for eradication and seasonal malaria chemoprevention (SMC) in West African countries. Vector resistance to Organochorines detected in 1955 in Nigeria, organophosphate, carbamate and pyrethroid resistance detected in the late 1980s and have expanded rapidly since the late 1990s8; CQ resistance detected in 1978, SP resistance in 1953 with significant clinical failure rates in 20009. Panel C: Climate - mean annual rainfall across the Sahara (Green line)10, El Niño events leading to serious climate anomalies including flooding in 1997-1998 in East Africa and drought in the horn of Africa in 2014-2015 (Red bars)11, monthly minimum temperature (Blue line)10.

We observed two precipitous declines in infection prevalence in 1945-49 and in 2005-2009. Dichlorodiphenyltrichloroethane (DDT) and chloroquine were introduced in 1945-1949, and the widespread introduction of insecticide treated bed nets (ITN) and artemisinin-based combination therapy (ACT) in 2005-2009 (Figure 2). Indoor residual house-spraying (IRS) with DDT was introduced through comparatively small projects during the 1950s and expanded in the 1960s only in southern Africa, Ethiopia, Sudan, Somalia and Madagascar. Expansion to national scales of ITN took over a decade following successful trial projects to reach moderate levels of coverage in Africa before 20107. Both precipitous declines in malaria prevalence followed rises in prevalence. The rise in median malaria prevalence during the period 1985-2004 led to a return to the prevalence witnessed fifty years earlier, before the introduction of DDT (Figure 2). This period also included: a) a rapid expansion of chloroquine resistance across Africa9; b) climate anomalies on the continent with changes in sea surface temperatures in the pacific10 (Figure 2); and c) failure of many national health agencies to prioritize the growing malaria epidemic because of lack of international donor assistance12. The period 1960 to 1984 was characterised by a slow decline in malaria prevalence across Africa (Figure 2). Remarkably, this coincided with a cessation of malaria elimination ambitions across much of SSA13, emerging resistance to organochloride insecticides14 and a period where malaria was integrated into broader health agendas, focussed on the presumptive treatment of fevers with choroquine (cheap, widely available and efficacious). This period also included drought across much of the Sahel10 (Figure 2) rendering some areas unsuitable for malaria transmission15. Hence several interventions may have influenced the observed trends, but no single factor appears sufficient. Despite impressive gains in the coverage of effective interventions since 2005, the rate of malaria prevalence reduction has slowed during the interval 2010-2015 (Figure 2). Continued challenges to malaria control include difficulties in ensuring access to ACTs and the threat of drug resistance, rapidly emerging insecticide resistance, and inadequate funding planning to replace long-lasting insecticide treated nets16. There has been an overall recession in malaria transmission intensity over the last 115 years. Independent abiotic factors related to economic growth may have contributed to this overall recession, but the constant growth in GDP17, urbanization18 or female education17, cannot explain the emerging malaria epidemic 1985-2004. Conversely, minimum temperatures across SSA have risen by over 1°C since the 1970s10 (Figure 2), and the linear phenomena of global warming cannot explain the precipitous declines in malaria prevalence witnessed after 2004. The interplay between malaria, climate, effective or failing intervention, human settlement and development is inevitably complex. Our analysis highlights that a focus on one factor alone is too simplistic and fails to adequately explain the cycles of parasite prevalence. The reduction in malaria transmission intensity has not occurred equally between countries or within countries (Figure 1), with more substantive declines and “shrinking of the map” at the margins of the historical range of P. falciparum transmission compared to the heartland of Africa’s most efficient vector species Anopheles gambiae s.s and An. colluzi, that forms a densely populated belt from West Africa, through central Africa down toward Mozambique. This remains the most significant part of the malaria endemic world today, was ignored after 196019,20 and risks being ignored today21. Our previous, and current, armoury of interventions did not, and will not, eliminate malaria in this part of the world. Caution is required in predicting a complex future, but if the future is consistent with the past we would predict further reductions in the range of and intensity of malaria transmission in Africa but punctuated with resurgences. We show the implausibility of simplistic explanations for temporal trends over the last 115 years, and therefore caution against simplistic explanations for the trend of the last 15 years (e.g. ascribing the trend to human intervention alone). The unique endemicity that prevails in Africa cannot be ignored in any global effort to eliminate P. falciparum, nor should we wait for a future storm to re-galvanize interest in a parasite that remains entrenched in across large parts of the continent.

Methods

Data Assembly

Over 21 years we sourced unpublished and published materials related to community-based malaria infection prevalence at European, United Nations and African national libraries, archives and ministry of health repositories. We undertook standard electronic data searches of peer-reviewed publications, and contacted malaria scientists, regional health research institutes, government and non-government agencies involved in the delivery and monitoring of malaria interventions (SI 1.3 and SI 1.4). The minimum data requirements for the survey included the date and location, age range, numbers examined, infection prevalence by species and parasite detection method. A total of 50,424 parasite prevalence surveys since 1900 were included4 (SI 1.5; Extended Data 1; Extended Data 2).

Spatial limits and resolution of malaria predictions

We excluded previously endemic north African countries (Morocco, Algeria, Tunisia, Libya and Egypt), off-shore islands and countries where malaria has not been described (Western Sahara and Lesotho). We used current national and sub-national first-level administrative boundary units used by the UNs GAUL project22, with adaptations for the margins of natural P. falciparum risk, disputed boundaries, dissolving small urban municipalities and to ensure contiguous shapes between sub-national units. Rwanda, Burundi, Djibouti, Swaziland and The Gambia were treated as single polygons (SI 2.1; SI 2.2; Source Data Figure 1). The natural spatial limits of P. falciparum risk were derived from expert opinion national maps and biological constraints (SI 2.2; Source Data Figure 1). The selection of 520 spatial polygons at the natural range of P. falciparum transmission is shown in Extended Data 3. Changing limits were mapped using data from national reports of malaria incidence since the 1960s (SI 2.3; Source Data Figure 1).

Statistical methods

We employed a Bayesian hierarchical binomial model that simultaneously estimates stable spatial and temporal structured patterns and departures from these stable components5. The input data were as follows: observed number of P. falciparum positive children aged 2-10 years, PfPR , and total number of tested children aged 2-10 ,n , for subnational region i = 1, … , 520 , and period t = 1, … , 16 (1900-1929, 1930-1944, and five year periods from 1945-1949 to 2010-2015). The model was fitted using Markov Chain Monte Carlo simulation using non-informative priors. Posterior distributions of parameters were obtained using WinBUGS software (SI 3; Source Data Figure 1). Gelman-Rubin statistics was used to assess model convergence (Extended Data 4). Observed versus fitted PfPR2-10 from the full model was used to validate output (Extended Data 5).
Extended Data 4

Model Convergence: Gelman-Rubin-Brooks plots demonstrating convergence during MCMC simulation for key model parameters. Black line represents ratio of within chain variability to between chain variability, the dark grey line represents the within-chain variability (pooled) and the light grey line represents the between-chain variability (average)

Extended Data 5

Model Validation: Predicted PfPR2-10 versus observed PfPR2-10 for 100 randomly selected data points. 99% of data points are within 95% credible interval (CI); Spearman Rank Correlation 0.46, P <0.001 (two-sided test)

Survey data in time: The temporal distribution of survey data per intervals selected for analysis (number of surveys shown on top of bars) Survey data in space: Location of 53,529 P. falciparum parasite surveys undertaken at 39,033 locations by time intervals from 1900-44 to 2010-15 The spatial range of P. falciparum Africa in between 1900-1950: light grey represents absence of natural P. falciparum transmission; pink is the natural extent of transmission; dark grey represents countries not included in the analysis Model Convergence: Gelman-Rubin-Brooks plots demonstrating convergence during MCMC simulation for key model parameters. Black line represents ratio of within chain variability to between chain variability, the dark grey line represents the within-chain variability (pooled) and the light grey line represents the between-chain variability (average) Model Validation: Predicted PfPR2-10 versus observed PfPR2-10 for 100 randomly selected data points. 99% of data points are within 95% credible interval (CI); Spearman Rank Correlation 0.46, P <0.001 (two-sided test)
  15 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 2.  The clay feet of the malaria giant and its African roots: hypotheses and inferences about origin, spread and control of Plasmodium falciparum.

Authors:  M Coluzzi
Journal:  Parassitologia       Date:  1999-09

3.  Climate change and the global malaria recession.

Authors:  Peter W Gething; David L Smith; Anand P Patil; Andrew J Tatem; Robert W Snow; Simon I Hay
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

4.  Insecticide-treated net coverage in Africa: mapping progress in 2000-07.

Authors:  Abdisalan M Noor; Juliette J Mutheu; Andrew J Tatem; Simon I Hay; Robert W Snow
Journal:  Lancet       Date:  2008-11-19       Impact factor: 79.321

Review 5.  Insecticide Resistance in African Anopheles Mosquitoes: A Worsening Situation that Needs Urgent Action to Maintain Malaria Control.

Authors:  Hilary Ranson; Natalie Lissenden
Journal:  Trends Parasitol       Date:  2016-01-27

6.  Lessons learned from applied field research activities in Africa during the malaria eradication era.

Authors:  L J Bruce-Chwatt
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

7.  Global malaria eradication and the importance of Plasmodium falciparum epidemiology in Africa.

Authors:  Robert W Snow
Journal:  BMC Med       Date:  2015-02-03       Impact factor: 8.775

8.  Use of space-time models to investigate the stability of patterns of disease.

Authors:  Juan Jose Abellan; Sylvia Richardson; Nicky Best
Journal:  Environ Health Perspect       Date:  2008-08       Impact factor: 9.031

Review 9.  Roll back malaria? The scarcity of international aid for malaria control.

Authors:  Vasant Narasimhan; Amir Attaran
Journal:  Malar J       Date:  2003-04-15       Impact factor: 2.979

10.  The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity.

Authors:  Abdisalan M Noor; Damaris K Kinyoki; Clara W Mundia; Caroline W Kabaria; Jonesmus W Mutua; Victor A Alegana; Ibrahima Socé Fall; Robert W Snow
Journal:  Lancet       Date:  2014-02-20       Impact factor: 202.731

View more
  81 in total

1.  4-Arylthieno[2,3-b]pyridine-2-carboxamides Are a New Class of Antiplasmodial Agents.

Authors:  Sandra I Schweda; Arne Alder; Tim Gilberger; Conrad Kunick
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

Review 2.  Ape Origins of Human Malaria.

Authors:  Paul M Sharp; Lindsey J Plenderleith; Beatrice H Hahn
Journal:  Annu Rev Microbiol       Date:  2020-09-08       Impact factor: 15.500

3.  In vivo anti-malarial activity of the hydroalcoholic extract of rhizomes of Kniphofia foliosa and its constituents.

Authors:  Yonatan Alebachew; Daniel Bisrat; Solomon Tadesse; Kaleab Asres
Journal:  Malar J       Date:  2021-01-01       Impact factor: 2.979

Review 4.  Antiplasmodial natural products: an update.

Authors:  Nasir Tajuddeen; Fanie R Van Heerden
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

Review 5.  Advances in integrative African genomics.

Authors:  Chao Zhang; Matthew E B Hansen; Sarah A Tishkoff
Journal:  Trends Genet       Date:  2021-11-02       Impact factor: 11.639

6.  Model building and assessment of the impact of covariates for disease prevalence mapping in low-resource settings: to explain and to predict.

Authors:  Emanuele Giorgi; Claudio Fronterrè; Peter M Macharia; Victor A Alegana; Robert W Snow; Peter J Diggle
Journal:  J R Soc Interface       Date:  2021-06-02       Impact factor: 4.118

7.  Vitamin D Deficiency and Its Association with Iron Deficiency in African Children.

Authors:  Reagan M Mogire; John Muthii Muriuki; Alireza Morovat; Alexander J Mentzer; Emily L Webb; Wandia Kimita; Francis M Ndungu; Alex W Macharia; Clare L Cutland; Sodiomon B Sirima; Amidou Diarra; Alfred B Tiono; Swaib A Lule; Shabir A Madhi; Andrew M Prentice; Philip Bejon; John M Pettifor; Alison M Elliott; Adebowale Adeyemo; Thomas N Williams; Sarah H Atkinson
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

8.  A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Plasmodium falciparum Malaria Infection in Western Kenya.

Authors:  Sally Peprah; Constance Tenge; Isaiah O Genga; Mediatrix Mumia; Pamela A Were; Robert T Kuremu; Walter N Wekesa; Peter O Sumba; Tobias Kinyera; Isaac Otim; Ismail D Legason; Joshua Biddle; Steven J Reynolds; Ambrose O Talisuna; Robert J Biggar; Kishor Bhatia; James J Goedert; Ruth M Pfeiffer; Sam M Mbulaiteye
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

9.  Pharmacological Assessment of the Antiprotozoal Activity, Cytotoxicity and Genotoxicity of Medicinal Plants Used in the Treatment of Malaria in the Greater Mpigi Region in Uganda.

Authors:  Fabien Schultz; Ogechi Favour Osuji; Anh Nguyen; Godwin Anywar; John R Scheel; Guy Caljon; Luc Pieters; Leif-Alexander Garbe
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

10.  Antiplasmodial and Cytotoxic Flavonoids from Pappea capensis (Eckl. & Zeyh.) Leaves.

Authors:  Nasir Tajuddeen; Tarryn Swart; Heinrich C Hoppe; Fanie R van Heerden
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.